These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 5191808

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Changes in schizophrenic intelligence under thioproperazine therapy.
    Askar AM, el-Guindy T, Shaheen O.
    J Egypt Med Assoc; 1969; 52(8):652-8. PubMed ID: 4391944
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [Noveril treatment of patients with treatment-resistant depressions (comparative evaluation of technics of intravenous drip administration)].
    Panteleeva GP, Borisova KE, Mikhaĭlova NM.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(8):1221-6. PubMed ID: 6149662
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [ECG picture in the course of treatment of schizophrenia with phenothiazine derivatives].
    Welbel L, Zalewski K.
    Psychiatr Pol; 1971; 5(1):49-54. PubMed ID: 5551991
    [No Abstract] [Full Text] [Related]

  • 48. The effect of thioproperazine on the activity of serum catalase in schizophrenic psychoses.
    Zapletálek M, Komenda S.
    Act Nerv Super (Praha); 1965 Aug; 7(3):265. PubMed ID: 4379825
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Psychopathological and cognitive correlates of tardive dyskinesia in schizophrenia and other disorders treated with neuroleptic drugs.
    Waddington JL.
    Adv Neurol; 1995 Aug; 65():211-29. PubMed ID: 7872142
    [No Abstract] [Full Text] [Related]

  • 52. The effects of drugs on objective measures of thought disorder in schizophrenic patients.
    Payne RW.
    Psychopharmacologia; 1972 Aug; 24(1):147-58. PubMed ID: 5018520
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Use of TPN-12 in 25 chronic schizophrenic patients].
    Medina Gil C, Samaniego Rodríguez C.
    Arch Neurobiol (Madr); 1969 Aug; 32(4):559-73. PubMed ID: 5380328
    [No Abstract] [Full Text] [Related]

  • 55. [Complications of combined use of lithium salts and neuroleptics in patients with endogenous psychoses].
    Mosolov SN.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983 Aug; 83(3):115-21. PubMed ID: 6134409
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia.
    Mackin P, Gallagher P, Watson S, Young AH, Ferrier IN.
    Aust N Z J Psychiatry; 2007 Apr; 41(4):321-6. PubMed ID: 17464718
    [Abstract] [Full Text] [Related]

  • 58. [Possibilities and limits of depot neuroleptic therapy of schizophrenic psychoses].
    Glatzel J.
    Ther Ggw; 1970 Jun; 109(6):834-6 passim. PubMed ID: 5453883
    [No Abstract] [Full Text] [Related]

  • 59. Effects of phenothiazine drugs on serum levels of apolipoproteins and lipoproteins in schizophrenic subjects.
    Wen F, Tan J.
    Acta Pharmacol Sin; 2003 Oct; 24(10):1001-5. PubMed ID: 14531942
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.